INS and hyperinsulinism: For most of them, a defect in the insulin signaling pathway translated to hepatic insulin resistance and hyperinsulinemia, with the exception of hepatic ablation of FoxO1, which exhibits normoinsulinemia and heightened insulin sensitivity [285], and hepatic Akt2, which showed indistinguishable insulin sensitivity as compared to control mice [286,287].